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INTRODUCTION
Shiga toxin (Stx)-producing Escherichia coli can cause a range
of illnesses from self-limiting watery diarrhea and hemorrhagic
colitis to severe conditions such as hemolytic uremic syn-
drome (HUS) and thrombotic thrombocytopenic purpura
(1). Stx binds to cell-surface glycosphingolipids, terminat-
ing in galactose- 1,4-galactose, whereupon the complex is
internalized, with resultant inhibition of peptide elongation
(2, 3). The major glycosphingolipid that binds Stx is galac-
tose- 1,4-galactose- 1,4-glucose ceramide (globotriaosyl-
ceramide: Gb3) in the case of Stx-1 and Stx-2, and globote-
traosylceramide (Gb4) for Stx-2e. These toxins are structurally
similar heterodimers composed of one enzymatically active
A subunit (4) that irreversibly inhibits protein synthesis by
means of its N-glycosidase activity on ribosomal subunit and
B subunit pentamer that binds Gb3 (5, 6).
Epigallocatechin-3-gallate (EGCG), a major ingredient of
green tea, has been known to have a variety of physiological
functions, such as anti-carcinogenic, anti-oxidant, anti-angio-
genic, anti-viral (7-9), and anti-bacterial activities (10-12).
Recently, others and we have showed that EGCG suppresses
mitogen-activated protein kinase (MAPKs), and NF- B acti-
vation (12, 13), and lipooxygenase and cyclooxygenase (COX)
activities (14), and arrest the cell cycle (15) in tumor cells. 
Differentiated intestinal epithelial cells express Gb3 (16),
and are sensitive to toxin-mediated cytotoxicity. Stx produced
in the intestine can be translocated to the bloodstream with-
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Epigallocatechin-3-gallate Suppresses Galactose- 1,4-galactose- 1,4-
glucose Ceramide Expression in TNF- Stimulated Human Intestinal
Epithelial Cells Through Inhibition of MAPKs and NF- B κ
Intestinal epithelial cells (IECs) have been known to produce galactose- 1,4-galac-
tose- 1,4-glucose ceramide (Gb3) that play an important role in the mucosal immune
response. The regulation of Gb3 is important to prevent tissue damage causing
shiga like toxin. Epigallocatechin-3-gallate (EGCG) has been studied as anti-car-
cinogenic, anti-oxidant, anti-angiogenic, and anti-viral activities, and anti-diabetic.
However, little is known between the expressions of Gb3 on IECs. The aim of this
study was to examine the inhibitory effect of EGCG, a major ingredient of green tea,
on Gb3 production via mitogen-activated protein kinases (MAPKs) and nuclear factor-
kappa B (NF- B) in the TNF- stimulated human colon epithelial cells, HT29. To
investigate how Gb3 is regulated, ceramide glucosyltransferase (CGT), lactosylce-
ramide synthase (GalT2), and Gb3 synthase (GalT6) were analyzed by RT-PCR
in HT 29 cells exposed to TNF- in the presence or absence of EGCG. EGCG dose-
dependently manner, inhibits TNF- induced Gb3 expression by blocking in both
the MAPKs and NF- B pathways in HT29 cells. TNF- enhanced CGT, GalT2 and
GalT6 mRNA levels and EGCG suppressed the level of these enzymes enhanced
by TNF- treatment.
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out cellular damage and can reach renal endothelial cells caus-
ing HUS (17, 18). Several studies support the idea that Stx
is important in the pathogenesis of bloody diarrhea that is
caused by damage of the intestinal epithelium. And recent
study has also demonstrated that invasion of the intestine in
vivo or of intestinal cells in vitro by Stx produces augmented
release of intestinal cytokines including IL-1, TNF- , IL-4,
and IL-10, suggesting that these cytokines may be important
in the pathogenesis of inflammatory diarrheal disease (19-22).
Especially, TNF- and IL-1 have been known to be impor-
tant cytokines to induce Gb3 and we here confirmed that
TNF- increases Gb3 synthesis through the upregulation
of ceramide glucosyltransferase (CGT), lactosylceramide syn-
thase (GalT2), and Gb3 synthase (GalT6) (23-26).
In this study, we investigated whether EGCG can suppress
TNF- induced Gb3 production, and EGCG has the poten-
tial to modulate Gb3 production through MAPKs (p38, c-
Jun N-terminal kinase (JNK)1/2, and ERK1/2), NF- B acti-
vation, and transcription of Gb3 synthesis enzymes in human
colon epithelial HT29 cells. To accomplish this, we exposed
intestinal cell lines to EGCG in vitro and analyzed the expres-
sion of Gb3. We found that EGCG inhibits TNF- induced
Gb3 synthesis by interfering with the MAPKs and NF- B
pathways in HT29 cells.
MATERIALS AND METHODS
Cell culture
A HT29 cell line was obtained from Korean Collection of
Cell Cultures (Seoul, Korea). HT29 cells were grown in RPMI
Medium 1640 (Gibco BRL, Gaithersburg, MD, U.S.A.) sup-
plemented with-glutamine, 25 mmol/L of HEPES buffer, and
sodium bicarbonate containing 10% fetal bovine serum (FBS),
penicillin, streptomycin sulfate, and sodium hydrogen carbon-
ate. The cells were incubated in humidified 5% CO2 atmo-
sphere at 37℃. EGCG was dissolved in dimethylsulfoxide
(DMSO). DMSO (0.01%), used as vehicle alone, did not affect
HT29 cells. Recombinant human TNF- (R&D Systems
Minneapolis, MN, U.S.A.) was used as a stimulator of HT29
cells. For all the studies carried out, cells were seeded at a low
density (5×106 cells/mL) in 12 well or 100 mm dishes. The
cells were allowed to attach overnight and rendered quiescent
through removal of feeding medium and its subsequent rep-
lacement with a serum-free medium 24 hr before the addition
of experimental media. And after the treatment of EGCG, the
media was changed daily to maintain the EGCG effect.
Apoptosis assay
Annexin V/PI staining was used to evaluate the survival
of the HT29 cells. Following specified treatments, the cells
were collected, washed with phosphate-buffered saline (PBS)
and resuspended in 100  L of annexin binding buffer (140
mM NaCl, 10 mM HEPES, pH 7.4, 25 mM CaCl2). Then,
5  L of annexin V-FITC conjugate (Biosource International,
Ridlington, Oxford, U.K.) and 2  L of propidium iodide (1
mg/mL) were added, and this suspension was incubated for
15 min at room temperature. The samples were then further
diluted with 400  L of annexin binding buffer. The cells were
analyzed by FACSCalibur (BD Biosciences, San Jose, CA,
U.S.A.). All of the annexin V-positive cells were considered
apoptotic (early and late), and their percentage among the
total number of cells was calculated. PI
+ Annexin V
- cells
were considered necrotic.
Flow cytometric analysis 
The pure Stx-IB subunit was dialyzed in a 0.1 M sodium
carbonate buffer (pH 7.4) for 24 hr. Fluorescein isothiocyanate
(FITC; Molecular Probes, Leiden, The Netherlands) was added
to 50  g/mg of the B subunit. The complexes were incubat-
ed at room temperature for 1 hr. The unreacted FITC was
removed by a process of gel filtration (Sephadex G25). After
24 hr, the culture in RPMI 1640 containing 0.5% FBS, HT29
cells were incubated with 0.5  L of Stx-IB-FITC on ice for
30 min. The stained cells were analyzed using a FACSCalibur.
RNA extraction and reverse transcription-PCR 
Total RNA was isolated from the harvested cells using the
TRIzol reagent (Gibco BRL). The concentration of total RNA
in the final elute could determine by spectrophotometry. The
total RNA (2  g) was converted to cDNA by reverse tran-
scriptase at 37℃ for 90 min using first-strand cDNA syn-
thesis kit (Amersham Pharmacia Biotech, NJ, U.S.A.). The
PCR profile included a 94℃denaturalization for 5 min fol-
lowed by 27 cycles of denaturalization at 94℃ for 30 sec,
annealing at 50℃ for 30 sec, extension at 72℃ for 30 sec,
and a final extension at 72℃ for 10 min. The primers used
in this study were as follows: for  -actin (GenBank accession
no. NM001101), forward primer 5′ -CAAGAGATGGCCAC-
GGCTGC-3′ and reverse primer 5′ -GCCAGTAGAGGCAG-
GGATGATGTTC-3′ , 251 bps, which yields a product size
of 274 bps; for ceramide glucosyltransferase (GenBank acces-
sion no. D50840), forward primer 5′ -CTTCTGAAACCAC-
TGAAAGG-3′and reverse primer 5′ -CAACTTCATATC-
CTGGCATT-3′ , 240 bps; for GalT6 (GenBank accession no.
AB037883), forward primer 5′ -GGATGCTTTGTTCTTT-
TCTG-3′and reverse primer 5′ -TTAAAATGCTTCTCCT-
GAGC-3′ , 239 bps; for GalT2 (GenBank accession no. AF09-
7159), forward primer 5′ -TCAACGGTACAGATTATCCC-
3′ and reverse primer 5′ -TTCCATCTGGGTTTACAGTC-
3′ , 249 bps; for  -galactosidase (GenBank accession no. NM_
000169), forward primer 5′ -CTTCTGAAACCACTGAA-
AGG-3′and reverse primer 5′ -CAACTTCATATCCTGG-
CATT-3′ , 253 bps. The final PCR products were loaded on550 D.-O. Moon, S.-R. Choi, C.-M. Lee, et al.
1.5% agarose gels. 
Western blot analysis for MAPKs 
Twenty-five  M EGCG-pretreated HT29 cells (5×106/mL)
were stimulated with TNF- (50 ng/mL). The cells were
rinsed twice with ice-cold PBS and harvested by scraping in
1 mL of ice-cold PBS. The pellets were resuspended in 100
L of lysis buffer (iNtRON Biotech, Korea) and incubated
on ice for 30 min. The lysates were removed by centrifuga-
tion at 15,000×g for 10 min. The samples were immedi-
ately aliquoted and stored frozen at -70℃. Protein concen-
trations were determined using a bicinchoninic acid protein
assay (Sigma, St. Louis. MO, U.S.A.). Thirty  g of protein
(homogenate) was separated by 10% SDS-polyacrylamide gels
and transferred to PVDF membranes (Millipore, MA, U.S.A.).
After blocking with 5% skim milk, the membranes were incu-
bated with antihuman-phospho-ERK antibody, antihuman-
phospho-JNK antibody, and antihuman-phospho-p38 anti-
body (Santa Cruz Biotech, CA, U.S.A.) for 12 hr at 4℃ and
then with anti-IgG-horseradish peroxidase (DAKO, High
Wycomde, Bucks, U.K.) for 1 hr. Epitopes on proteins rec-
ognized specifically by antibodies were visualized by using
enhanced chemiluminescence (ECL) detection reagents (Amer-
sham Pharmacia Biotech). After stripping, the membranes
were reprobed with antihuman ERK antibody, antihuman
JNK antibody, and antihuman p38 antibody (Santa Cruz
Biotech) as the respective loading controls. 
Extraction of cytosolic and nuclear proteins and Western
blot analysis for NF- B 
Cytosolic and nuclear extracts were separated by 10% SDS-
PAGE to detect NF- B, respectively, and transferred to PVDF
membranes (Millipore). After blocking with 5% skim milk,
NF- B membranes, respectively, were incubated with anti-
human NF- B (p65) (Santa Cruz Biotech) for 12 hr at 4℃.
Membranes were incubated with the anti-IgG-horseradish
peroxidase (DAKO) for 1 hr. Epitopes recognized specifically
by antibodies were visualized by using ECL detection reagents.
Statistical analysis 
The results were expressed as the mean±S.E. for the num-
ber of experiments. The statistical significance was compared
among each treated group and the control by a Student’s t-
test. Each experiment was repeated at least three times and
yielded comparable results. Values with p<0.05 were consid-
ered significant. 
RESULTS
EGCG was non-toxic and non-apoptotic to HT29 cells in
vitro
EGCG has been reported to reduce cell proliferation and
to induce cell apoptosis in some tumor cell lines (27), with
the TNF- pathway is also linked to apoptosis via JNK/P38.
We experimented the effect of EGCG and TNF- to prove
Fig. 2. Effect of TNF- on Gb3 induction in HT29 cells. (A) Dose-
dependent effect of TNF- on Gb3 production. TNF- treated
dose-dependently (10, 25, 50, and 100 ng/mL) for 2 days in HT29
cells. And time-dependent effect of TNF- on Gb3 production.
The cells were cultured with TNF- (50 ng/mL) for 0, 12, 24, 48,
and 72 hr. (B) The intensity was measured by densitometry. Iso-
type control represents the thick lines. The values are the mean±
S.E. of duplicate determinations from three separate experiments.
The sigmificance was determined by Student’s t-test (*, p<0.05).
MFI, mean fluorescence intensity.
Fig. 1. Flow cytometric analysis of HT29 cell death. The HT29 cells
pretreated with EGCG (25  M) were cultured for 48 hr with TNF-
(50 ng/mL) and were analyzed by flow cytometric analysis using
annexin V-FITC and propidium iodide. LL quadrant: viable cells
(annexin V and propidium iodide negative cells); LR quadrant:
apoptotic cells (annexin V positive and propidium iodide negative
cells); UR quadrant: dead cells (annexin V and propidium iodide
positive cells). Numbering refers to the cell percentage of each
population. Number of counted cells: 10,000.
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whether Gb3 inhibition by EGCG is associated with cell
apoptosis in cultured HT29 cells. Subconfluent dishes of
HT29 cells were treated with EGCG (25  M), TNF- (50
ng/mL) and EGCG with TNF- for 48 hr, and apoptosis was
measured by FACS. Those concentrations did not affect cell
viability and did not induce apoptosis (Fig. 1).
TNF- stimulated the expression of Gb3 in HT29 cells
Dose-response analyses for TNF- from 10 to 100 ng/mL
and for the time course from 12 hr to 72 hr were performed.
TNF- increased the Gb3 expression in HT29 cells in a time-
and concentration-dependent manner (Fig. 2).
EGCG suppressed Gb3 expression in HT29 cells
Then, it was investigated whether or not EGCG would affect
the TNF- induced Gb3 expression in HT29 cells. The HT29
cells were pretreated with four doses of EGCG (10, 25, and
50  M) for 2 hr and then stimulated with TNF- for 2 days,
and Gb3 expression was examined by FACS. Gb3 induction
was derived by TNF- (50 ng/mL) and significantly decreased
in cells treated with EGCG 25 and 50  M (Fig. 3B). DMSO
(0.01%) used as vehicle did not affect on the Gb3 induction
from TNF- - stimulated HT29 cells (data not shown). TNF-
increased the Gb3 content on the HT29 cells about 2.5 folds,
and remarkably decreased the Gb3 content in cells pretreat-
ed with 25 and 50  M of EGCG.
EGCG inhibited TNF- -induced MAPK phosphorylation 
To determine if EGCG has the ability to block the activa-
tion of MAPKs, the HT29 cells were pretreated with EGCG
2 hr prior to TNF- stimulation. Our results showed that
EGCG inhibits all three MAPK subgroup, ERK, JNK1/2,
and p38-MAPK, in TNF- -pretreated HT29 cells, without
affecting the total levels of these kinases (Fig. 4). A scanning
analysis of the blots revealed that the phosphorylation inhi-
bitory effect of EGCG was more evident. These results indi-
cate that MAPK phosphorylation was inhibited by EGCG
pretreatment.
Effect of EGCG on TNF- -induced NF- B nuclear
translocation 
It has been shown that TNF- activates a variety of signal
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Fig. 3. Effect of EGCG on Gb3 induction in TNF- stimulated HT29
cells. (A) The HT29 cells pretreated with EGCG (10, 25, and 50  M)
were cultured for 2 days with TNF- (50 ng/mL), and were analyzed
by FACS. (B) The inhibitory effect of EGCG on Gb3 induction by
TNF- was shown in a dose-dependent manner. Isotype control
represents the thin lines. Analysis of Gb3 content was carried out
using FACS. MFI, mean fluorescence intensity.
Fig. 4. Effect of EGCG on ERK1/2, JNK1/2, and p38 phosphory-
lation in TNF- -stimulated HT29 cells. (A) The HT29 cells pretreat-
ed with EGCG (25  M) were cultured for 15 min with TNF- (50
ng/mL), and were analyzed by Western blot using phospho-p38,
phospho-JNK1/2 and phospho-ERK1/2 antibodies. (B) The inten-
sity was measured by densitometry. The values are the mean±
S.E. from three separate experiments (*p<0.05).
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pathways, including that of NF- B (24), which plays a criti-
cal role in regulating various genes. To determine whether
EGCG blocks TNF- -induced activation of NF- B, a nuclear
extract was prepared from HT29 cells treated with TNF-
and EGCG; nuclear translocation of the NF- B, p65 sub-
unit was detected by western blot. The TNF- -mediated
NF- B (p65) increase in the nuclei was blocked by the treat-
ment of EGCG (Fig. 5A). 
EGCG suppressed TNF- -induced CGT, GalT2, and
GalT6 mRNA expression 
Gb3 synthesis is associated with three glycosphingolipid
enzymes (Fig. 6). Each of the three enzymes involved in Gb3
synthesis (CGT, GalT2, and GalT6), as well as the enzyme
involved in Gb3 degradation ( -galactosidase), was evaluated.
This set of experiments investigated the mechanisms respon-
sible for the inhibition of TNF- -stimulated Gb3 expression
in HT29 cells. CGT, GalT2, and GalT6 mRNA in-EGCG
(25  M) pretreated HT29 cells were analyzed by RT-PCR.
CGT, GalT2 and GalT mRNA accumulation was induced
by TNF- and remarkably decreased in cells pretreated with
EGCG (25  M) (Fig. 7). These finding indicate that EGCG
A
B
Cytosolic p65
Control TNF- EGCG EGCG
+TNF-
Nuclear p65
O
p
t
i
c
a
l
 
d
e
n
s
i
t
y
 
u
n
i
t
20,000
16,000
12,000
8,000
4,000
0
Control TNF TNF+EGCG EGCG
Cytosolic p65
*
*
O
p
t
i
c
a
l
 
d
e
n
s
i
t
y
 
u
n
i
t
20,000
16,000
12,000
8,000
4,000
0
Control TNF TNF+EGCG EGCG
Nuclear p65
*
*
Fig. 5. Effect of EGCG on NF- B p65 nuclear translocation in TNF- -
stimulated HT29 cells. (A) The EGCG (25  M)-pretreated cells were
stimulated for 2 hr with TNF- (50 ng/mL), and then were analyzed
by Western blot using the anti-NF- B p65 antibody. (B) The opti-
cal density unit was measured by densitometry. The values are
the mean±S.E. from three separate experiments (*p<0.05).
Fig. 6. Scheme of the Gb3 biosynthetic pathway. Depicted are the
three enzymes and their respective products of the Gb3 pathway
of eukaryotic cells (26).
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Fig. 7. Effect of EGCG on CGT, GalT2, and GalT6 mRNA expres-
sion in TNF- -stimulated HT29 cells. (A) The HT29 cells pretreated
with EGCG (25  M) were cultured for 24 hr with TNF- (50 ng/mL),
and were analyzed by RT-PCR for CGT, GalT2, GalT6, and  -
galactosidase mRNA. (B) A PCR using housekeeping gene  -
actin mRNA was carried out in parallel to confirm the equivalency
of cDNA preparation. Relative intensity represents mRNA levels
of CGT, GalT2, GalT6, and  -galactosidase/ -actin. The values
are the mean±S.E. from three separate experiments (*p<0.01).
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(25  M) suppresses CGT, GalT2, and GalT6 mRNA levels
that are related to Gb3 synthesis. In contrast,  -galactosidase
activity was not changed by TNF- alone, and was co-treat-
ed with EGCG.
DISCUSSION
Infections with Stx-producing E. coli have been known to
induce intestinal cytokines including IL-1 and TNF- . These
cytokines play an important role in the interactions of bac-
teria with mucosal surface and are known to increase the
binding of E. coli to intestines (28) and the Gb3 content in
intestinal cells. And during the development of HUS, Stx
may work cooperate with LPS and the LPS-induced cytokines
TNF- and IL-1 to damage vascular endothelial cells and
intestinal epithelial cells.
It has been demonstrated that TNF- , IL-1 , and bacte-
rial LPS require 24 to 48 hr to maximally sensitize endothe-
lial cells to the Stx, but intestinal glycoconjugates have not
been clearly demonstrated to be involved in Gb3 induction
by these cytokines or LPS (25, 26). 
Accordingly, our first set of experiments was designed to
confirm that the inflammatory cytokine TNF- can induce
Gb3 production. We have demonstrated here that the incu-
bation of HT29 cells with TNF- markedly enhances the
Gb3 contents in the cells.
The effects of EGCG on the activation of MAPK members
in selected cell lines have also been reported. It was shown
that treatment with EGCG inhibited the ultraviolet-B-in-
duced activation of p38-MAPK in the human keratinocyte
cell line (29), whereas other studies showed have shown that
EGCG activated all three MAPK families including the extra-
cellular signal-regulated kinase (ERK1/2), JNK, and p38 in
HeLa cells (30). In vascular smooth muscle cells, EGCG inhib-
ited the platelet-derived growth factor- -induced activation
of ERK1/2 in a dose-dependent manner (15). In addition,
EGCG selectively inhibited the interleukin-1 -induced acti-
vation of JNK, but not ERK1/2 or p38 MAPK, in human
osteoarthritis chondrocytes (31). Thus, it appears that the
MAPK-activating or inhibitory effects of EGCG may be stim-
ulus- and/or cell type-dependent (13). 
EGCG has been studied to make use of its biological effects
including anti-oxidant, anti-proliferative, anti-cancer (7-9),
and anti-bacterial activities (10-12). Interestingly, EGCG
has the potency to inhibit production and/or release of Stx
from EHEC cells (32). In this study, we examined the effect
of EGCG on Gb3 production and its mechanism of action
in regulating the MAPKs and NF- B pathways in HT29
cells. We observed that the pretreatment of EGCG resulted
in the inhibition of TNF- -mediated MAPK phosphoryla-
tion and NF- B activation.
Also, TNF- has been known to increase the transcription
of CGT and GalT2,6 enzymes (23) that are related to the Gb3
production pathway in eukaryotic cells. The promoters of
these three enzymes contain an NF- B-recognition site (25).
EGCG also decreased the enzymes related to the Gb3 synthe-
sis pathway via the transcription level regulation of NF- B
activation. Based on our results, we proposed a hypothetical
scheme explaining EGCG actions on Gb3 production in
Fig. 8. 
Taken together, our data clearly indicates that EGCG in-
hibits TNF- -mediated Gb3 synthesis by blocking both the
MAPKs and the NF- B pathways in HT29 cells. Thus, it is
plausible to propose that EGCG regulates the Gb3 expression
of host colonic cells in situ and that consumption of EGCG
may alter the interaction of Stx family toxins with the mucosa
and reduce disease expression in humans, especially during
seasonal food-poisoning periods. 
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